Inflammatory Bowel Disease Treatment Global Market Report 2022 – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Others), By Type (Crohn's Disease, Ulcerative Colitis), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : August 2022 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The inflammatory bowel disease treatment market consists of sales of inflammatory bowel disease therapeutics and drugs by entities (organizations, partnerships, and sole proprietors) that are used to provide medical treatment for inflammatory bowel diseases. Inflammatory bowel disease refers to two medical conditions, Crohn’s disease and ulcerative colitis, characterized by chronic inflammation of the gastrointestinal (GI) tract. Treatment for inflammatory bowel disease aims to minimize the inflammation, maintain remission, and prevent complications.

The main classes of inflammatory bowel disease treatment include aminosalicylates, corticosteroids, TNF inhibitors, IL inhibitors, anti-integrin, JAK inhibitors, and others. Aminosalicylates refer to a class of medications used to treat and prevent ulcerative colitis flare-ups and Crohn's disease. The function of aminosalicylates is based on inhibiting the production of cyclo-oxygenase and prostaglandin, thromboxane synthetase, platelet-activating factor synthetase, and interleukin-1 by macrophages. Both orally and injectable-administered inflammatory bowel disease treatments are used in the treatment of Crohn’s disease and ulcerative colitis. These drugs are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The inflammatory bowel disease treatment market research report is one of a series of new reports from The Business Research Company that provides inflammatory bowel disease treatment market statistics, including inflammatory bowel disease treatment industry global market size, regional shares, competitors with an inflammatory bowel disease treatment market share, detailed inflammatory bowel disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the inflammatory bowel disease treatment industry. This inflammatory bowel disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The global inflammatory bowel disease market size is expected to grow from $19.52 billion in 2021 to $20.48 billion in 2022 at a compound annual growth rate (CAGR) of 4.93%. The global inflammatory bowel disease market size is expected to grow to $24.84 billion in 2026 at a compound annual growth rate (CAGR) of 4.94%.

The rising prevalence of Crohn’s disease and ulcerative colitis is significantly driving the inflammatory bowel disease treatment market. Crohn’s disease and ulcerative colitis are types of inflammatory bowel diseases (IBD) that cause inflammation and ulcers (sores) in the digestive tracts. The rising cases of Crohn’s disease and ulcerative colitis are expected to boost demand for inflammatory bowel disease treatments, as they are being widely used to reduce bowel inflammation and reduce and prevent medical complications. For instance, according to a 2019 report by the Crohn's & Colitis Foundation (CCFA), around 1.6 million Americans currently (2019) suffer from inflammatory bowel disease (Crohn’s disease or ulcerative colitis), showing an increase of around 200,000 since the last time it reported this figure in 2011. Around 70,000 new cases of IBD are diagnosed every year in the USA. Hence, the rising prevalence of Crohn’s disease and ulcerative colitis is expected to drive the inflammatory bowel disease treatment market.

Technological advancement is a key trend gaining popularity in the inflammatory bowel disease treatment market. The key players in the inflammatory bowel disease treatment market are focusing on using technology such as artificial intelligence (AI) for the drug discovery process as well as offering advanced but new inflammatory bowel disease treatments. To attain their technological innovations, key players and technology companies are partnering to leverage each other's competencies and technology to develop new treatments and strengthen their key position in the market. For instance, in May 2021, CytoReason, an Israeli technology start-up developing a computational model of the human body, partnered with Ferring Pharmaceuticals, a Switzerland-based multinational pharmaceutical company, to develop new inflammatory bowel disease treatments (IBD) using artificial intelligence technology during the drug discovery process. Ferring's medical expertise will be combined with CytoReason's artificial intelligence (AI) technology to create cell-centered illness models. The AI technology enables scientists to gain critical information on the body’s functioning and treat diseases at the cellular level.

In January 2019, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, acquired Shire plc for an undisclosed amount. Takeda intends to use this acquisition to accelerate its research and development activities in highly innovative drugs while also expanding its global business presence. Shire plc is a USA-based biopharmaceutical company involved in providing various pharmaceutical drugs, including drugs for inflammatory bowel diseases.

Major players in the inflammatory bowel disease treatment market are AbbVie Inc, Biogen, Johnson & Johnson, Amgen Inc, UCB SA, Novartis AG, Takeda Pharmaceutical Company Limited, Merck & Co, Pfizer Inc, Abbott Laboratories, Janssen Biotech Inc, Eli Lilly, Allergan plc, Alkem Laboratories Limited, and Bausch Health Companies Inc.

North America was the largest region in the inflammatory bowel disease treatment market in 2021. Asia-Pacific is expected to be the fastest-growing region in the inflammatory bowel disease treatment market during the forecast period. The regions covered in the global inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the inflammatory bowel disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The global inflammatory bowel disease treatment market is segmented -

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Others

2) By Type: Crohn's Disease, Ulcerative Colitis

3) By Route of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

    Table Of Contents

    1. Executive Summary

    2. Inflammatory Bowel Disease Treatment Market Characteristics

    3. Inflammatory Bowel Disease Treatment Market Trends And Strategies

    4. Impact Of COVID-19 On Inflammatory Bowel Disease Treatment

    5. Inflammatory Bowel Disease Treatment Market Size And Growth

    5.1. Global Inflammatory Bowel Disease Treatment Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Inflammatory Bowel Disease Treatment Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Inflammatory Bowel Disease Treatment Market Segmentation

    6.1. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Aminosalicylates

    Corticosteroids

    TNF inhibitors

    IL inhibitors

    Anti-integrin

    JAK inhibitors

    Others

    6.2. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Oral

    Injectable

    6.3. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Crohn's Disease

    Ulcerative Colitis

    6.4. Global Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital Pharmacy

    Retail Pharmacy

    Online Pharmacy

    7. Inflammatory Bowel Disease Treatment Market Regional And Country Analysis

    7.1. Global Inflammatory Bowel Disease Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Inflammatory Bowel Disease Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Inflammatory Bowel Disease Treatment Market

    8.1. Asia-Pacific Inflammatory Bowel Disease Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. Asia-Pacific Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Inflammatory Bowel Disease Treatment Market

    9.1. China Inflammatory Bowel Disease Treatment Market Overview

    9.2. China Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    9.3. China Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Inflammatory Bowel Disease Treatment Market

    10.1. India Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. India Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Inflammatory Bowel Disease Treatment Market

    11.1. Japan Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Japan Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Inflammatory Bowel Disease Treatment Market

    12.1. Australia Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. Australia Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Inflammatory Bowel Disease Treatment Market

    13.1. Indonesia Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.2. Indonesia Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Inflammatory Bowel Disease Treatment Market

    14.1. South Korea Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.2. South Korea Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Inflammatory Bowel Disease Treatment Market

    15.1. Western Europe Inflammatory Bowel Disease Treatment Market Overview

    15.2. Western Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Western Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Inflammatory Bowel Disease Treatment Market

    16.1. UK Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.2. UK Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Inflammatory Bowel Disease Treatment Market

    17.1. Germany Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.2. Germany Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Inflammatory Bowel Disease Treatment Market

    18.4. France Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.5. France Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Inflammatory Bowel Disease Treatment Market

    19.1. Eastern Europe Inflammatory Bowel Disease Treatment Market Overview

    19.2. Eastern Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. Eastern Europe Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Inflammatory Bowel Disease Treatment Market

    20.1. Russia Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.2. Russia Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Inflammatory Bowel Disease Treatment Market

    21.1. North America Inflammatory Bowel Disease Treatment Market Overview

    21.2. North America Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. North America Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Inflammatory Bowel Disease Treatment Market

    22.1. USA Inflammatory Bowel Disease Treatment Market Overview

    22.2. USA Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. USA Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Inflammatory Bowel Disease Treatment Market

    23.1. South America Inflammatory Bowel Disease Treatment Market Overview

    23.2. South America Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. South America Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Inflammatory Bowel Disease Treatment Market

    24.1. Brazil Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.2. Brazil Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Inflammatory Bowel Disease Treatment Market

    25.1. Middle East Inflammatory Bowel Disease Treatment Market Overview

    25.2. Middle East Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25.3. Middle East Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Inflammatory Bowel Disease Treatment Market

    26.1. Africa Inflammatory Bowel Disease Treatment Market Overview

    26.2. Africa Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26.3. Africa Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Inflammatory Bowel Disease Treatment Market Competitive Landscape And Company Profiles

    27.1. Inflammatory Bowel Disease Treatment Market Competitive Landscape

    27.2. Inflammatory Bowel Disease Treatment Market Company Profiles

    27.2.1. AbbVie Inc

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Biogen

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Johnson & Johnson

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Amgen Inc

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. UCB SA

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Inflammatory Bowel Disease Treatment Market

    29. Inflammatory Bowel Disease Treatment Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Inflammatory Bowel Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Inflammatory Bowel Disease Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Inflammatory Bowel Disease Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Asia-Pacific, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: China, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: China, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: India, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: India, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Japan, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: Japan, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Australia, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: Australia, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Indonesia, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Indonesia, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: South Korea, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: South Korea, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: Western Europe, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Western Europe, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: UK, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: UK, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Germany, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28: Germany, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29: France, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30: France, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31: Eastern Europe, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32: Eastern Europe, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33: Russia, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34: Russia, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35: North America, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36: North America, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37: USA, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38: USA, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39: South America, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40: South America, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41: Brazil, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42: Brazil, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43: Middle East, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44: Middle East, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45: Africa, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46: Africa, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 47: AbbVie Inc Financial Performance
  • Table 48: Biogen Financial Performance
  • Table 49: Johnson & Johnson Financial Performance
  • Table 50: Amgen Inc Financial Performance
  • Table 51: UCB SA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Inflammatory Bowel Disease Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Inflammatory Bowel Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Inflammatory Bowel Disease Treatment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Inflammatory Bowel Disease Treatment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Asia-Pacific, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Asia-Pacific, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: China, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: China, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: India, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: India, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Japan, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: Japan, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Australia, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: Australia, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Indonesia, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Indonesia, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: South Korea, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: South Korea, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: Western Europe, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Western Europe, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: UK, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: UK, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Germany, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28: Germany, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29: France, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30: France, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31: Eastern Europe, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32: Eastern Europe, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33: Russia, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34: Russia, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35: North America, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36: North America, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37: USA, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38: USA, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39: South America, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40: South America, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41: Brazil, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42: Brazil, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43: Middle East, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44: Middle East, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45: Africa, Inflammatory Bowel Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46: Africa, Inflammatory Bowel Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 47: AbbVie Inc Financial Performance
  • Figure 48: Biogen Financial Performance
  • Figure 49: Johnson & Johnson Financial Performance
  • Figure 50: Amgen Inc Financial Performance
  • Figure 51: UCB SA Financial Performance
Global Heparin Market Size, Forecasts, And Opportunities – Includes Heparin Market Report
Global Generic Pharmaceuticals Market Outlook, Opportunities And Strategies – Includes Generic Pharmaceuticals Market Size
Global Hormonal Contraceptives Market Outlook, Opportunities And Strategies – Includes Hormonal Contraceptives Market Size
Global Immuno-Oncology Drugs Market Size, Forecasts, And Opportunities – Includes Immuno-Oncology Drugs Market Trends
Global Biosimilars Market Outlook, Opportunities And Strategies – Includes Biosimilars Vs Generic
Global Cancer Monoclonal Antibodies Market Size, Forecasts, And Opportunities – Includes Cancer Monoclonal Antibodies Market Share
Global Coronavirus (COVID-19) Current Therapy Market Outlook, Opportunities And Strategies – Includes Coronavirus (COVID-19) Current Therapy Market Analysis
Global Autoimmune Disease Diagnosis Market Size, Forecasts, And Opportunities – Includes Autoimmune Disease Diagnosis Market Analysis
Smart Pills Global Market Report 2022 – By Application (Capsule Endoscopy, Patient Monitoring, Drug Delivery), By End User (Hospital, Diagnostic Center, Research Institute), By Target Area (Esophagus, Stomach, Small Intestine, Large Intestine), By Disease Indication (Esophageal Diseases, Colon Diseases, Small bowel Diseases, and Other Disease Indications) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Microbiome Global Market Report 2022 – By Type (Fecal Microbiota Transplantation (FMT), Microbiome drugs), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis), By Technology (Genomics, Proteomics, Metabolomics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Digestive Enzymes Global Market Report 2022 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Biosimilar Interleukins Global Market Report 2022 – By Type (IL-17, IL-23, IL-1, IL-5, IL-6), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease (IBD)), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Clinics, Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022 – By Product (Adalimumab Biosimilars (Exemptia, Mabura, Hyrimoz, Hadlima, Abrilada, Others), Infliximab Biosimilars (Inflectra, Renflexis, Ixifi, Avsola), Cipleumab (Erelzi, Eticovo)), By Application (Crohn’S Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Oral Biologics & Biosimilar Drugs Global Market Report 2022 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn'S Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
TNF Alpha Inhibitors Global Market Report 2022 – By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab)), By Route Of Administration (Oral, Subcutaneous, Intravenous), By Disease Type (Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Microbiome Therapeutics Global Market Report 2022 – By Product (Probiotics, Prebiotics, Symbiotics, and Other Products), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, and Other Applications), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, and E-commerce Stores) – Market Size, Trends, And Global Forecast 2022-2026
View Report